VADERIS THERAPEUTICS
Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.
VADERIS THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2019-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.vaderis.com
Total Employee:
11+
Status:
Active
Total Funding:
18 M CHF
Technology used in webpage:
Google Maps IONOS
Similar Organizations
AgeCurve
World’s First Deep Age Profiling from Home
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
G.ST Antivirals
G.ST Antivirals focuses on the development of antiviral drugs.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Picea Biosolutions
Picea Biosolutions is a biotechnology firm that develops tailored expression systems for enzymes from picoliter to large-scale fermentation.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Investors List
Medicxi
Medicxi investment in Series A - Vaderis Therapeutics
Official Site Inspections
http://www.vaderis.com Semrush global rank: 14.76 M Semrush visits lastest month: 37
- Host name: 217-160-0-130.elastic-ssl.ui-r.com
- IP address: 217.160.0.130
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Vaderis Therapeutics"
Vaderis Home - Vaderis
Vaderis is developing an oral medicine known as VAD044 which, if successful, will both treat the symptoms of HHT and will reduce the occurrence of new lesions, thereby modifying disease progression of HHT. OUR PARTNERS. …See details»
Leadership Team - Vaderis
Vaderis Therapeutics AG WSJ-350 3.05, Lichtstrasse 35, 4056 Basel, Switzerland +41 79 592 …See details»
Vaderis Therapeutics AG – Swiss Biotech
Vaderis Therapeutics AG is a clinical stage biotech focussing on treatment of rare diseases …See details»
Vaderis Therapeutics AG | European Clinical Trials Information …
Vaderis Therapeutics AG is a Swiss-based biotech company that specializes in developing …See details»
Vaderis Therapeutics - Crunchbase Company Profile & Funding
Organization. Vaderis Therapeutics . Connect to CRM . Save . Summary. Financials. People. …See details»
Vaderis - Overview, News & Competitors | ZoomInfo.com
Vaderis is a clinical stage biotechnology company focussed on the treatment of rare diseases …See details»
Vaderis Therapeutics Company Profile 2024: Valuation, Funding ...
Vaderis Therapeutics was founded in 2019. Where is Vaderis Therapeutics headquartered? …See details»
Vaderis scores win against rare blood vessel disorder as trial shows ...
Dec 2, 2024 Vaderis Therapeutics’ goal to develop the first drug aimed specifically at a …See details»
Vaderis - Biotech Careers
Vaderis is a clinical stage biotechnology company focused on the treatment of rare and orphan …See details»
Vaderis Forms to Tackle Vascular Malformations with Novartis Vet …
Aug 22, 2022 Currently, there are no FDA-approved drugs specifically for the treatment of …See details»
Press Release: Vaderis Receives FDA Fast Track Designation for ...
Nov 18, 2024 The below press release was issued Monday, Nov. 18 by Vaderis Therapeutic, …See details»
BioCentury - Vaderis: A case study in navigating the orphan drug ...
Oct 24, 2024 In the six years it took to progress from an idea to clinical proof of concept, …See details»
About Vaderis - Vaderis
Laboratories used for scientific research take many forms because of the differing …See details»
Vaderis Operations GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vaderis …See details»
Vaderis Receives FDA Fast Track Designation for VAD044 for the ...
Nov 18, 2024 Vaderis is developing VAD044, an oral, once-daily allosteric AKT-inhibitor, the …See details»
Vaderis Leadership Group Archives - Vaderis
Vaderis Therapeutics AG WSJ-350 3.05, Lichtstrasse 35, 4056 Basel, Switzerland +41 79 592 …See details»
Vaderis' rare blood vessel disorder drug reduces nosebleeds
Aug 27, 2024 Vaderis Therapeutics’ goal to develop the first drug aimed specifically at a …See details»
Nicholas Benedict - Vaderis
EXPERIENCE. Serial biotech entrepreneur with substantial track record over 30 years in the …See details»
Vaderis Therapeutics Policy on Expanded Access
Expanded Access Policy. To serve patients, Vaderis conducts clinical trials with the goal of …See details»